{"schema_version":"secwatch.filing_event.v1","accession":"0001193805-21-001455","form_type":"8-K","ticker":"IMUX","cik":"0001280776","company_name":"IMMUNIC, INC.","filed_at":"2021-10-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.893791+00:00","generated_at":"2026-06-28T20:29:08.612739+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Immunic appoints Patrick Walsh as Chief Business Officer; $380K salary, 120K options","bullets":["Patrick Walsh appointed Chief Business Officer, effective Oct 14, 2021.","Base salary $380,000, signing bonus $60,000, options for 120,000 shares.","Options vest 25% on first anniversary, then monthly over 36 months; target bonus min 35%.","Severance: 12 months' base salary on termination without cause; 33% equity vesting (100% near change of control).","Previously VP Business Development at Akebia Therapeutics; earlier roles at AVEO, Capgemini, Leerink."],"urls":{"canonical":"https://secwatch.observer/filing/0001193805-21-001455","json":"https://secwatch.observer/filing/0001193805-21-001455.json","markdown":"https://secwatch.observer/filing/0001193805-21-001455.md","text":"https://secwatch.observer/filing/0001193805-21-001455.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1280776/000119380521001455/0001193805-21-001455-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1280776/000119380521001455/e621010_8k-immunic.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T20:29:08.612739+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b2ef63ade3","claim":"Patrick Walsh was appointed as Chief Business Officer at IMMUNIC, INC..","evidence_excerpt":"On October 14, 2021, the board of directors (the “Board”) of Immunic, Inc. (the “Company”) appointed Patrick Walsh as the Chief Business Officer, effective October 14, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1280776/000119380521001455/0001193805-21-001455-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Business Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}